跳至主要内容
临床试验/EUCTR2004-000088-92-IT
EUCTR2004-000088-92-IT进行中(未招募)不适用

A randomised, double-blind,placebo-controlled, multi-centre, dose escalation study to evaluate the safety and the preliminary efficacy of recombinant factor VIIa (NovoSeven/Niastase) in subjects with brain contusions.

OVO NORDISK0 个研究点目标入组 96 人开始时间: 2005年4月12日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
OVO NORDISK

相似试验

已完成
3 期
A randomised, double-blind, placebo-controlled,multicentre prospective dose-finding Phase II/III studywith atacicept given subcutaneously to subjects havingrecently experienced a flare of systemic lupuserythematosus (SLE)SLEsystemic lupus1000381610010761
NL-OMON39295Merck BV - An affiliate of Merck Serono S.A.34
进行中(未招募)
不适用
Study with the herbal preparation STW5-II in patients with mild to moderate ulcerative colitis (chronic inflammatory bowel disease)lcerative colitis
EUCTR2013-000891-13-DESteigerwald Arzneimittelwerk GmbH
已完成
3 期
A double-blind, randomised, placebo-controlled multicenter study to asses the safety and efficacy of AST-120 in mild to moderately active Crohn's patients with fistulas.inflamattory bowel dissease10017969
NL-OMON30808Ocera Therapeutics, Inc.9
进行中(未招募)
1 期
A randomized, double-blind, placebo-controlled multi-centre phase II study to evaluate efficacy and tolerability of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)Metastatic Castration Resistant Prostate Cancer (CRPC)MedDRA version: 17.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2014-002054-39-DKDexTech Medical AB66
进行中(未招募)
1 期
Study of efficacy and safety of secukinumab in Psoriatic Arthritis and axial Spondyloarthritis patients with active enthesitis including one Achilles tendon site (ACHILLES)Psoriatic arthritis Axial spondyloarthritisMedDRA version: 19.0 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 19.0 Level: PT Classification code 10071400 Term: Axial spondyloarthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2016-000972-91-GRovartis Pharma Services AG200